Azenta Inc
NASDAQ:AZTA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
40.37
67.51
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Azenta Inc
Azenta Inc
Total Equity
Azenta Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Azenta Inc
NASDAQ:AZTA
|
Total Equity
$1.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Equity
$49B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Equity
$51.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Equity
-$154.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Equity
$5.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Equity
$7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Azenta Inc
Glance View
Azenta Inc. emerged as a focused entity after the strategic divestiture of Brooks Automation's semiconductor business, carving out a niche to serve the life sciences industry with precision. The company's evolution is a testament to its strategic agility, aligning itself with the burgeoning demand for data-driven decision-making in healthcare and biotechnology. Azenta specializes in providing comprehensive solutions that revolve around sample management, genomic services, and automated storage systems. By ensuring the integrity and accessibility of biological samples and data, Azenta plays a crucial role in accelerating research and development processes. Its core operations are built upon intricate platforms that manage critical laboratory activities and genomic sequencing, enabling laboratories and research institutions to streamline their workflows and enhance productivity. Central to Azenta's business model is its recurring revenue stream derived from life science products and services, which supports labs in safeguarding and optimizing essential research materials. The company's offerings encompass robust automated systems, state-of-the-art genomic services, and logistics that ensure seamless sample management from collection to analysis. Through strategic partnerships and continuous innovation, Azenta effectively supports its clients in navigating the complexities of modern research, ultimately helping translate scientific endeavors into tangible outcomes. By continually expanding its technological capabilities and service offerings, Azenta not only fortifies its market position but also underscores its commitment to facilitating transformative advancements in life science and healthcare industries.
See Also
What is Azenta Inc's Total Equity?
Total Equity
1.8B
USD
Based on the financial report for Sep 30, 2024, Azenta Inc's Total Equity amounts to 1.8B USD.
What is Azenta Inc's Total Equity growth rate?
Total Equity CAGR 10Y
11%
Over the last year, the Total Equity growth was -30%. The average annual Total Equity growth rates for Azenta Inc have been 10% over the past three years , 9% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
